Monobenzone, formerly known as Benoquin, is a tyrosinase inhibitor used to treat vitiligo by depigmentation. Monobenzone may cause destruction of melanocytes. References: Zhu Y, Wang S, Xu A. A mouse model of vitiligo induced by monobenzone. Exp Dermatol. 2013 Jul;22(7):499-501. doi: 10.1111/exd.12184. PubMed PMID: 23800067.

纯度：≥98%

CAS：103-16-2